LUMACAFTOR - AN OVERVIEW

CRC has an immunosuppressive TME which helps prevent the development of a successful reaction to ICB therapies. There is thus an urgent should detect the strategies reprogram this suppressive TME in an effort to boost immunotherapy efficacy. In The existing analyze, we applied CRISPR KO screens to discover genes that sensitize CRC to antitumor immu